Optimising Isolation, Quarantine and Distancing for COVID-19
A RPOC test to identify contacts and asymptomatic cases
COVID-19 Vaccine Development
Transparent Risk Assessment of Quarantine Study
Burnet's innovative and evidence-based public health and laboratory-based COVID-19 research initiatives are contributing to solutions to the global pandemic. Scroll for a full list.
Since the commencement of the COVID-19 pandemic, Burnet has been proactively contributing to the response through public health and laboratory-based research, advocacy and in the provision of high-level advice to State and Federal governments.
The Institute’s key programs - Disease Elimination, Behaviours and Health Risks, Health Security, and Maternal, Child and Adolescent Health - are home to researchers with significant expertise and longstanding collaborations and networks that are critical to the local, national and global response to COVID-19.
Burnet’s expertise in virology, rapid diagnostics, and in assessing and developing antiviral agents is well recognised internationally. Combined with our public health expertise in epidemiology, modelling, disease elimination and understanding human behaviours, Burnet is well positioned to provide a significant ongoing contribution to the COVID-19 response in Australia and overseas.
In addition, 360biolabs (a Burnet majority owned Contract Research Organisation) is Australia’s first commercially focused ISO accredited laboratory to offer virology and immunology testing for COVID-19 vaccine development, and laboratory testing of new antivirals and biologics.
Another Burnet spinoff company, Nanjing BioPoint Diagnostics Technology, will supporting proof-of-concept and validation studies for rapid point-of-care diagnostics for COVID-19 being developed at Burnet.
Our efforts are focused on how we can pivot our resources and expertise to support the Australian and global research and public health efforts.
Bringing together some of Australia’s smartest minds, Burnet is also co-leading a Victorian Consortium, with Doherty Institute, to lead a collaborative research approach to tackling COVID-19. Start-up funding provided by the Victorian State Government is recognition of the many decades which we have been building capacity, the complementary nature of each institute’s technical expertise, and the unique role we can play in the response to this virus.
PUBLIC HEALTH AND SOCIAL IMPACT RESEARCH
Professor Margaret Hellard AM, is leading Burnet’s COVID-19 Public Health and Social Impact research. Current priorities include a series of studies to:
Assess how to reduce ongoing transmission of COVID-19.
Assess the impact of the broader social and economic impact of the mitigation efforts (including self-isolation) introduced by the government and identify ways to reduce negative consequences of these mitigation efforts.
HOW YOU CAN HELP US FIGHT COVID-19
While we possess the technical capacity and have received initial funding we are reaching out to the philanthropic sector to boost funding to accelerate research into life saving outcomes.
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present. We recognise and respect the cultural heritage of this land.
It looks like something may have gone wrong, and some of the resources required to load the page may not have loaded correctly.